Pediatric Vaccines Market Size

Pediatric Vaccines Market Size

Pediatric Vaccines Market size was valued at USD 48.1 billion in 2023 growing at a CAGR of 8.9% from 2024 and 2032, due to rising prevalence of infectious and chronic disease among children. The outbreaks of diseases such as measles, mumps, and rubella create an urgent need for vaccination.

To get key market trends

  Download Free Sample

For instance, as per the report published by World Health Organization in April 2024, it has been reported that there were an estimated 136,000 measles deaths globally, mostly among unvaccinated or under vaccinated children under the age of 5 years. Similarly, in 2022, 74% of children received both doses of the measles vaccine, and about 83% of the world's children received one dose of measles vaccine by their first birthday. Thus, the increasing prevalence of chronic and infectious disease and rise in awareness and education about the importance of vaccination among parents and caregivers lead to higher uptake rates, thereby contributing to the market growth.
 

A pediatric vaccine is a vaccine designed to protect infants, and children from various infectious diseases. These vaccines are formulated to be safe and effective for younger populations and are typically administered according to a recommended immunization schedule. Pediatric vaccines help prevent diseases such as measles, mumps, rubella, polio, diphtheria, tetanus, pertussis (whooping cough), hepatitis, influenza, and more. They play a crucial role in promoting public health by reducing the incidence of these diseases and preventing outbreaks.